Oct 19, 2026 04:05PM

Oct 12, 2026 06:52AM

Oct 12, 2026 02:24AM

Sep 23, 2026 04:06PM

Aug 11, 2026 04:16PM

Jun 14, 2026 02:01PM

Jun 1, 2026 01:46PM Jefferies on Mineralys Therapeutics, Inc. (MLYS): 'Historical Trends Suggests M&A Is Still Statistically Possible Before PDUFA'

Jun 1, 2026 06:59AM

May 6, 2026 04:41PM

Apr 27, 2026 05:29AM

Mar 13, 2026 12:40PM

Mar 13, 2026 07:59AM

Mar 13, 2026 07:33AM

Mar 12, 2026 04:14PM Mineralys Therapeutics, Inc. (MLYS) Tops Q4 EPS by 54c

Mar 10, 2026 09:32AM

Mar 10, 2026 06:12AM

Dec 19, 2025 07:40AM

Nov 10, 2025 04:20PM

Nov 6, 2025 02:26PM

Sep 8, 2025 07:13AM

Sep 3, 2025 05:33AM Mineralys Therapeutics, Inc. (MLYS) PT Raised to $26 at Jefferies

Aug 18, 2025 02:08PM

Aug 12, 2025 04:09PM

Jul 14, 2025 08:20AM

Jun 30, 2025 11:19AM

Jun 18, 2025 06:44AM

Jun 17, 2025 07:00AM

Jun 10, 2025 04:15PM Jefferies Starts Mineralys Therapeutics, Inc. (MLYS) at Hold

May 20, 2025 08:01AM

May 12, 2025 04:28PM

Apr 23, 2025 05:25PM

Mar 31, 2025 08:18AM

Mar 17, 2025 08:00AM

Mar 11, 2025 10:20PM

Mar 10, 2025 04:03PM Goldman Sachs Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)

Mar 10, 2025 04:01PM

Mar 10, 2025 10:40AM

Mar 10, 2025 07:01AM

Mar 7, 2025 04:01PM

Feb 25, 2025 09:40AM

Feb 12, 2025 07:04AM

Feb 4, 2025 08:06AM Mineralys Therapeutics (MLYS) Completes Enrollment in Explore-CKD Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects with Stage 2 to 3b CKD and Albuminuria

Jan 8, 2025 08:06AM

Nov 11, 2024 04:06PM

Aug 14, 2024 05:52AM

Aug 14, 2024 05:23AM

Aug 13, 2024 04:07PM

Jul 10, 2024 06:18AM

Jun 14, 2024 08:01AM Mineralys Therapeutics (MLYS) Appoints Alexander M. Gold to its Board

471,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All